This inventor holds 1 USPTO granted patent and 4 published patent applications and 3 EPO patents. Top assignee: Small Pharma Ltd. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Lorraine Sharp: Innovator in Pharmaceutical Chemistry
Introduction
Lorraine Sharp is a notable inventor based in Penicuik, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. Her work focuses on enhancing the solubility and stability of important pharmaceutical agents.
Latest Patents
Lorraine holds a patent for "Crystalline forms of hydroxynorketamine." This invention provides novel, stable, processable, and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamine or 2S,6S-hydroxynorketamine with high aqueous solubility. This advancement is crucial for improving the delivery and efficacy of these compounds in medical applications.
Career Highlights
Lorraine Sharp is associated with Small Pharma Ltd, where she applies her expertise in pharmaceutical development. Her innovative approach has led to advancements in drug formulation, making her a valuable asset to her company and the industry.
Collaborations
Throughout her career, Lorraine has collaborated with notable colleagues, including David Pearson and Alan Armstrong. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Lorraine Sharp's contributions to pharmaceutical chemistry exemplify the impact of innovation in the medical field. Her work on hydroxynorketamine is a testament to her dedication to improving drug formulations and patient outcomes.